Celldex Therapeutics Inc (CLDX)

Celldex (CLDX) Financial Statements


Celldex Financial Overview

Celldex's market cap is currently ―. The company's EPS TTM is $-2.844; its P/E ratio is -12.98; Celldex is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 1.52M$ 268.00K$ 967.00K$ 1.61M$ 407.00K
Gross Profit$ 1.52M$ 268.00K$ 967.00K$ 1.61M-
EBIT$ -38.26M$ -30.50M$ -29.36M$ -27.89M$ -27.70M
EBITDA-$ -30.91M$ -29.89M$ -27.73M$ -27.02M
Net Income Common Stockholders$ -38.26M$ -30.50M$ -29.36M$ -26.49M$ -26.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 235.35M$ 252.70M$ 278.39M$ 304.95M$ 323.47M
Total Assets$ 280.26M$ 299.31M$ 324.52M$ 352.74M$ 369.23M
Total Debt$ 2.85M$ 3.25M$ 3.65M$ 4.03M$ 3.63M
Net Debt$ -232.50M$ -249.44M$ -274.74M$ -300.92M$ -319.84M
Total Liabilities$ 33.54M$ 21.77M$ 21.78M$ 352.74M$ 23.81M
Stockholders Equity$ 246.72M$ 277.54M$ 302.74M$ 326.20M$ 345.42M
Cash Flow-
Free Cash Flow-$ -27.61M$ -29.18M$ -22.01M$ -35.54M
Operating Cash Flow$ -19.00M$ -27.20M$ -28.60M$ -21.77M$ -35.19M
Investing Cash Flow$ 11.65M$ 1.16M$ 52.57M$ 31.21M$ 23.07M
Financing Cash Flow$ 257.00K$ 133.00K$ 694.00K$ 1.40M$ 2.31M
Currency in USD

Celldex Earnings and Revenue History

Celldex Debt to Assets

Celldex Cash Flow

Celldex Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis